Document is current
Any future updates will be listed below
-
Authors
Bhatnagar, Pallav
Ahmad, Nadia N.
Li, Xuan https://orcid.org/0000-0002-6169-2640
Coghlan, Matthew
Kaplan, Lee M.
Farooqi, I. Sadaf https://orcid.org/0000-0001-7609-3504
- License Information
-
More Information
Article History
Received: 10 November 2024
Accepted: 24 July 2025
First Online: 26 August 2025
Competing interests
: I.S.F. has consulted for Eli Lilly, Novo Nordisk, Sanofi, Nodthera Therapeutics and Rhythm Pharmaceuticals on anti-obesity medications. L.M.K. is a scientific and/or medical consultant to Altimmune, Amgen, Boehringer Ingelheim, Cytoki, Gilead, Johnson & Johnson, Kallyope, Eli Lilly and Company, Novo Nordisk, Optum, Perspectum, Pfizer, Xeno Biosciences and Zealand. N.N.A., M.C., X.L. and P.B. are employees and shareholders of Eli Lilly and Company.
